1. Regulatory T cells and breast cancer: implications for immunopathogenesis

   • Maria Angelica Ehara Watanabe
   • Julie Massayo Maeda Oda
   • Julio Cesar Voltarelli

   NON-THEMATIC REVIEW 11 September 2010 Pages: 569 - 579

   

2. Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials

   • Christos J. Markopoulos

   NON-THEMATIC REVIEW Open access 10 September 2010 Pages: 581 - 594

   

3. Expression of tenascin-C and its isoforms in the breast

   • David S. Guttery
   • Jacqueline A. Shaw
   • Rosemary A. Walker

   NON-THEMATIC REVIEW 04 September 2010 Pages: 595 - 606

   

4. Induction chemotherapy response and recurrence rates in correlation with N0 or N+ stage in oral squamous cell cancer (OSCC)

   • Lajos Olasz
   • Enikő Orsi
   • József Szalma

   NON-THEMATIC REVIEW 15 September 2010 Pages: 607 - 611

   

5. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network

   • Lakshmanane Boominathan

   NON-THEMATIC REVIEW 05 October 2010 Pages: 613 - 639

   

6. Obesity and breast cancer: status of leptin and adiponectin in pathological processes

   • Michael E. Grossmann
   • Amitabha Ray
   • Margot P. Cleary

   NON-THEMATIC REVIEW 07 September 2010 Pages: 641 - 653

   

7. DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability

   • Mehmet Şahin
   • Emel Şahin
   • Meral Gültekin

   NON-THEMATIC REVIEW 07 September 2010 Pages: 655 - 676

   

8. DNA repair pathways and their implication in cancer treatment

   • Athanasios G. Pallis
   • Michalis V. Karamouzis

   NON-THEMATIC REVIEW 07 September 2010 Pages: 677 - 685

   

9. Feedback regulation of proteasome gene expression and its implications in cancer therapy

   • Youming Xie

   NON-THEMATIC REVIEW 11 September 2010 Pages: 687 - 693

   

10. Perspectives on the mesenchymal origin of metastatic cancer

    • Leanne C. Huysentruyt
    • Thomas N. Seyfried

    NON-THEMATIC REVIEW Open access 14 September 2010 Pages: 695 - 707

    

11. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

    • Xueqing Sun
    • Guangcun Cheng
    • Jianhua Wang

    NON-THEMATIC REVIEW 14 September 2010 Pages: 709 - 722

    

12. Cytochrome P450-derived eicosanoids: the neglected pathway in cancer

    • Dipak Panigrahy
    • Arja Kaipainen
    • Sui Huang

    NON-THEMATIC REVIEW Open access 13 October 2010 Pages: 723 - 735

    

13. Distant metastases do not metastasize

    • Dieter Hölzel
    • Renate Eckel
    • Jutta Engel

    NON-THEMATIC REVIEW 29 September 2010 Pages: 737 - 750

    

14. The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

    • Carlos A. Castaneda
    • Hernán Cortes-Funes
    • Eva M. Ciruelos

    NON-THEMATIC REVIEW 05 October 2010 Pages: 751 - 759

    

15. Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis

    • Phulwinder K. Grover
    • Jennifer E. Hardingham
    • Adrian G. Cummins

    NON-THEMATIC REVIEW 28 September 2010 Pages: 761 - 775

    

16. Malignant melanoma as a target malignancy for the study of the anti-metastatic properties of the heparins

    • Anthony Maraveyas
    • Miriam J. Johnson
    • Simon Noble

    NON-THEMATIC REVIEW Open access 09 October 2010 Pages: 777 - 784

    

17. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis

    • Ming Shi
    • Dan Liu
    • Ning Guo

    NON-THEMATIC REVIEW 12 October 2010 Pages: 785 - 799

    

18. Erratum to: microRNAs and lung cancer: tumors and 22-mers

    • Liqin Du
    • Alexander Pertsemlidis

    Erratum 10 June 2010 Pages: 801 - 802